Chemoradiation OR Brachytherapy for RECTal Cancer
This research is being done to compare the effectiveness of high dose endorectal brachytherapy (END-HDR) and the standard treatment option of chemoradiation with Capecitabine in the treatment of cancer of the lowest part of the bowel (rectum).
100 Clinical Results associated with Nucletron BV /Management/
0 Patents (Medical) associated with Nucletron BV /Management/
100 Deals associated with Nucletron BV /Management/
100 Translational Medicine associated with Nucletron BV /Management/